TriMas Corporation $TRS Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. reduced its holdings in TriMas Corporation by 0.6%, owning approximately 3,873,939 shares worth $90,766,000 as of the latest SEC filing.
• Despite Vanguard's reduction, other institutional investors like Bank of America and Pzena Investment Management have increased their stakes in TriMas, indicating ongoing interest in the company.
• TriMas reported earnings of $0.61 per share for the last quarter, surpassing analysts' expectations, and has set an annual EPS guidance of $1.950-$2.100 for FY 2025.

Vanguard Group Inc. trimmed its position in TriMas Corporation (NASDAQ:TRS - Free Report) by 0.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,873,939 shares of the industrial products company's stock after selling 22,007 shares during the quarter. Vanguard Group Inc. owned about 9.53% of TriMas worth $90,766,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Deutsche Bank AG grew its stake in shares of TriMas by 45.6% during the 4th quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company's stock worth $893,000 after purchasing an additional 11,363 shares during the period. GAMMA Investing LLC increased its stake in TriMas by 3,802.9% during the 1st quarter. GAMMA Investing LLC now owns 14,948 shares of the industrial products company's stock worth $350,000 after buying an additional 14,565 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of TriMas by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company's stock worth $568,000 after acquiring an additional 834 shares during the last quarter. Envestnet Asset Management Inc. raised its stake in TriMas by 44.5% in the 1st quarter. Envestnet Asset Management Inc. now owns 22,765 shares of the industrial products company's stock valued at $533,000 after purchasing an additional 7,016 shares during the last quarter. Finally, Wells Fargo & Company MN raised its holdings in TriMas by 21.1% in the 4th quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock valued at $928,000 after acquiring an additional 6,573 shares during the last quarter. 99.42% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at TriMas

In other news, Director Adrianne Shapira acquired 4,000 shares of the company's stock in a transaction dated Thursday, June 5th. The shares were bought at an average price of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the purchase, the director directly owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders bought a total of 5,266 shares of company stock worth $137,188 in the last 90 days. Insiders own 14.20% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. BWS Financial reaffirmed a "buy" rating and issued a $45.00 price target (up previously from $40.00) on shares of TriMas in a research note on Wednesday, July 30th. KeyCorp set a $45.00 target price on shares of TriMas and gave the company an "overweight" rating in a report on Tuesday, August 12th. Finally, Wall Street Zen upgraded TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, TriMas currently has an average rating of "Buy" and a consensus target price of $45.00.

TriMas Price Performance

NASDAQ:TRS traded down $0.07 during trading hours on Wednesday, hitting $38.67. The company's stock had a trading volume of 335,444 shares, compared to its average volume of 428,121. The company has a market capitalization of $1.57 billion, a PE ratio of 42.50 and a beta of 0.66. TriMas Corporation has a 52-week low of $19.33 and a 52-week high of $39.09. The business's 50-day moving average is $32.38 and its two-hundred day moving average is $26.72. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.44 and a current ratio of 2.59.

TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.11. TriMas had a return on equity of 11.49% and a net margin of 3.83%.The business had revenue of $274.76 million during the quarter, compared to the consensus estimate of $251.18 million. During the same quarter in the previous year, the company posted $0.43 EPS. The business's revenue was up 14.2% on a year-over-year basis. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS. As a group, research analysts anticipate that TriMas Corporation will post 1.69 EPS for the current fiscal year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Investors of record on Tuesday, August 5th were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.4%. The ex-dividend date was Tuesday, August 5th. TriMas's dividend payout ratio is currently 17.58%.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.